BioSig Announces Closing of 3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

BSGM Stock  USD 1.34  0.04  3.08%   
About 55% of BioSig Technologies,'s investors are presently thinking to get in. The analysis of overall sentiment of trading BioSig Technologies, Common otc stock suggests that some investors are interested at this time. BioSig Technologies,'s investing sentiment overview a quick insight into current market opportunities from investing in BioSig Technologies, Common. Many technical investors use BioSig Technologies, stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
BioSig Technologies, otc stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of BioSig daily returns and investor perception about the current price of BioSig Technologies, Common as well as its diversification or hedging effects on your existing portfolios.
  
Westport, CT, May 30, 2024 -- BioSig Technologies, Inc. a medical technology company committed to delivering unprecedented accuracy and precision to

Read at benzinga.com
benzinga news
  

BioSig Technologies, Fundamental Analysis

We analyze BioSig Technologies,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of BioSig Technologies, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of BioSig Technologies, based on its fundamental data. In general, a quantitative approach, as applied to this otc stock, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Current Asset

Current Asset Comparative Analysis

BioSig Technologies, is currently under evaluation in current asset category among its peers. Current Asset is all of the company's assets that can be used to pay off current liabilities within the current fiscal period or over the next 12 months. Current Asset includes cash or cash equivalents, accounts receivable, short-term investments, and the portion of prepaid liabilities which will be paid within the next 12 months. Because these assets are easily turned into cash, they are sometimes referred to as liquid assets.

BioSig Technologies, Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BioSig Technologies, otc stock to make a market-neutral strategy. Peer analysis of BioSig Technologies, could also be used in its relative valuation, which is a method of valuing BioSig Technologies, by comparing valuation metrics with similar companies.

Peers

BioSig Technologies, Related Equities

HSCSHeart Test   11.99   
0%
100.0%
VVOSVivos Therapeutics   6.87   
0%
57.0%
CLPTClearpoint Neuro   6.07   
0%
50.0%
TIVCTivic Health   5.00   
0%
41.0%
CTSOCytosorbents Crp   4.55   
0%
37.0%
LUNGPulmonx Corp   3.71   
0%
30.0%
BMRABiomerica   3.70   
0%
30.0%
NPCENeuropace   3.50   
0%
29.0%
NMTCNeuroone Medical   2.70   
0%
22.0%
INGNInogen   2.05   
0%
17.0%
TELATela Bio   1.79   
0%
14.0%
APYXApyx Medical   0.64   
0%
5.0%
SRDXSurModics   0.40   
3.0%
0%
KIDSOrthopediatrics Corp   0.93   
7.0%
0%
NUWENuwellis   0.99   
8.0%
0%
BJDXBluejay Diagnostics   1.54   
12.0%
0%
BBLGBone Biologics   3.81   
31.0%
0%
XAIRBeyond Air   4.76   
39.0%
0%
NAOVNanoVibronix   4.92   
41.0%
0%

Other Information on Investing in BioSig OTC Stock

BioSig Technologies, financial ratios help investors to determine whether BioSig OTC Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BioSig with respect to the benefits of owning BioSig Technologies, security.